Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Nuwacell Logo
Nuwacell Growth Score
69
CB Rank
62783
Heat Score
70
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.
Founded
obfuscation
PrivateSeries B Hefei, Anhui, China11-50 m.nuwacell.com/
Health Care
Medical
Therapeutics
Overview

Nuwacell
Total Funding
obfuscation
Growth Score
69
Heat Score
70

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score69
-5 pts
in past quarter
Heat Score 70
-5 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Nuwacell

CB Rank
62783
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.
Founded
obfuscation
PrivateSeries B Hefei, Anhui, China11-50 m.nuwacell.com/
Health Care
Medical
Therapeutics

Funding Rounds

Series B
OBF
in
obfuscation
Series B
OBF
in
obfuscation
Series A
OBF
in
obfuscation

Details

Legal Name Anhui Zhongsheng Suyuan Biotechnology Co., Ltd.
Also Known As 安徽中盛溯源生物科技有限公司, 中盛溯源, Zhongsheng Tracing, Zhongsheng Source
Operating Status Active
Company Type For Profit
Phone Number +86 4008883920
Contact Email service@nuwacell.com
Predictions & Insights

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

NCR100
An iPSC-derived mesenchymal stem cell (iMSC) therapy product for treating knee osteoarthritis, currently in Phase II clinical trials.
NCR101
A gene-modified iPSC-derived mesenchymal stem cell (iMSC) therapy targeting interstitial lung disease, in Phase I/II clinical trials.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B
obfuscation
Series B - Nuwacell Logo
Series B - Nuwacell
4
obfuscation
— Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Nansha Kejin Holding Group Logo
Nansha Kejin Holding Group
—
Series B - Nuwacell Logo
Series B - Nuwacell
—
Nansha Kejin Holding Group Logo
Nansha Kejin Holding Group
—
Series B - Nuwacell Logo
Series B - Nuwacell
—
Nansha Kejin Holding Group Logo
Nansha Kejin Holding Group
—
Series B - Nuwacell Logo
Series B - Nuwacell
—
Nansha Kejin Holding Group Logo
Nansha Kejin Holding Group
—
Series B - Nuwacell Logo
Series B - Nuwacell
—
Nansha Kejin Holding Group Logo
Nansha Kejin Holding Group
—
Series B - Nuwacell Logo
Series B - Nuwacell
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50
News
Technology
View Tech Report

Active Website Tech Count

5Nuwacell is actively using 5 technologies for its website, according to BuiltWith. These include CommonCrawl Top 50m, Euro, and  Pound Sterling.

Total IP

14The intellectual property of Nuwacell includes 13 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, Nuwacell has 1 registered trademark in the 'Pharmaceutical, veterinary and sanitary products' class, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Nuwacell's headquarters? Nuwacell is located in Hefei, Anhui, China.Who invested in Nuwacell? Nuwacell has 11 investors including Nansha Kejin Holding Group and  Hefei Industrial Investment Guozheng Equity Investment.When was the last funding round for Nuwacell? Nuwacell closed its last funding round on
obfuscation
from a Series B round.Who are Nuwacell's competitors? Alternatives and possible competitors to Nuwacell may include Shenzhen Capital Group, Lyell Immunopharma, and  Century Therapeutics.How much funding has Nuwacell raised to date? Nuwacell has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|